Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) EBIT Margin (2019 - 2025)

Historic EBIT Margin for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to 61.05%.

  • Outset Medical's EBIT Margin rose 131300.0% to 61.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 55.83%, marking a year-over-year increase of 438900.0%. This contributed to the annual value of 55.83% for FY2025, which is 438900.0% up from last year.
  • Outset Medical's EBIT Margin amounted to 61.05% in Q4 2025, which was up 131300.0% from 53.73% recorded in Q3 2025.
  • Outset Medical's EBIT Margin's 5-year high stood at 53.68% during Q2 2025, with a 5-year trough of 174.49% in Q2 2022.
  • Over the past 5 years, Outset Medical's median EBIT Margin value was 120.02% (recorded in 2022), while the average stood at 111.03%.
  • Per our database at Business Quant, Outset Medical's EBIT Margin surged by 1816000bps in 2021 and then crashed by -558900bps in 2022.
  • Outset Medical's EBIT Margin (Quarter) stood at 144.92% in 2021, then increased by 14bps to 124.42% in 2022, then increased by 2bps to 122.44% in 2023, then skyrocketed by 39bps to 74.18% in 2024, then rose by 18bps to 61.05% in 2025.
  • Its EBIT Margin stands at 61.05% for Q4 2025, versus 53.73% for Q3 2025 and 53.68% for Q2 2025.